Zou Y L, Tan X, Tian T, Li L, Li Z X, Cheng W, Wang Z X
Department of Plastic Surgery, the First Affiliated Hospital of Army Medical University (the Third Military Medical University), Chongqing 400038, China.
Zhonghua Shao Shang Za Zhi. 2019 Apr 20;35(4):266-276. doi: 10.3760/cma.j.issn.1009-2587.2019.04.006.
To study the clinical effect of nano-fat mixed granule fat transplantation in the treatment of cicatricial facial depression and atrophy, and to explore the related experimental mechanism. (1) From January 2012 to April 2018, 105 patients conforming to the inclusion criteria, with cicatricial facial depression and atrophy deformity who needed facial fat transplantation, were admitted to our unit. Their medical records were analyzed retrospectively. According to the patients' wishes, 54 patients (12 males and 42 females) aged 10-59 years received traditional transplantation of pure autologous granule fat collected from abdomen/thigh and were included in simple transplantation group, while the other 51 patients (14 males and 37 females) aged 7-63 years received transplantation of autologous nano-fat mixed granule fat collected from abdomen/thigh and were included in mixed transplantation group. The treatment satisfaction of patients 3 and 6 months after operation was assessed by the facial fullness, symmetry, scar, and complications using self-made scales and photo data before and after operation. Six months after operation, the patients were assessed whether they needed to undergo a second operation, and the rate of second operation was calculated. During the second operation, the fat of patients transplanted in the first operation was collected, and the morphology of adipocytes and microangiogenesis was observed under a scanning electron microscope. (2) Adipose-derived stem cells (ADSCs) were isolated and cultured from abdominal fat of a 4-week-old male Sprague-Dawley (SD) rat. The 5th passage of cells were selected to observe cell morphology after cultured for 14 days, observe expression of vimentin and cytokeratin-18 by immunofluorescence method, identify osteogenic and adipogenic differentiation, and detect rates of CD29 and CD44 positive cells by flow cytometer (=3). Eighteen 4-week-old male SD rats were divided into ADSCs transplantation group, simple scar group, and blank control group according to the random number table, with 6 rats in each group. Rats in ADSCs transplantation group and simple scar group were subcutaneously injected with 1 mL bleomycin which was dissolved in phosphate buffered saline (PBS) with a mass concentration of 1 mg/mL at the back to establish scar models. After 3 hours, rats in ADSCs transplantation group were injected with 1×10(6) ADSCs suspended in 0.1 mL PBS at the same injection site, while rats in simple scar group were injected with 0.1 mL PBS. Rats in blank control group were injected with the same doses of PBS in the same place at the same two time points mentioned above. After continuous injection for 28 days in each group, the full-thickness skin tissue of the injected area of all rats was collected to observe the collagen fibers by Masson staining and expressions of α-smooth muscle actin (α-SMA) and transforming growth factor β(1) (TGF-β(1)) by immunohistochemistry, and the positive cells were counted. Data were processed with Mann-Whitney test, (2) test, one-way analysis of variance, and least significant difference test. (1) Compared with the preoperative condition, the facial fullness and symmetry of patients in simple transplantation group were better in 3 months after operation, with scar color closer to the surrounding skin, and the filling volume of patients in this group decreased in 6 months after operation as compared with that in 3 months after operation. In mixed transplantation group, the facial fullness and symmetry of patients were better in 3 and 6 months after operation as compared with the preoperative condition, with scar color and texture closer to the surrounding skin, and the filling volume in 6 months after operation was not obviously reduced as compared with that in 3 months after operation. Fat liquefaction and subcutaneous nodule formation occurred respectively in 1 patient in simple transplantation group within 3 months after operation. The treatment satisfaction of patients in mixed transplantation group was significantly higher than that in simple transplantation group in 3 and 6 months after operation (=-2.566, -3.084, <0.05 or <0.01). Six months after operation, the second operation rate of patients in mixed transplantation group was 7.84% (4/51), which was significantly lower than 22.22% (12/54) in simple transplantation group ((2)=4.199, <0.05). At the second operation, compared with those of simple transplantation group, the cells of fat transplanted in the first operation of patients in mixed transplantation group were more plump, without collapse or dryness, and the cells were closely arranged, with smaller gap; the tubular and the cord-like microvascular structure on the cell surface were more abundant, and the cell gap was full of network-like microvascular structure that grew into the adipose tissue. (2) The fifth passage of cells isolated and cultured from rat fat grew adherently to the wall, with long fusiform or spindle shape, showing shoal-of-fish-like growth. Vimentin and cytokeratin-18 were highly expressed in the cells. Cells showed osteogenic and adipogenic differentiation ability by induction. The positive expression rates of CD29 and CD44 were higher than 90.00%. The cells were identified as ADSCs. After 28 days of injection, the collagen fibers in the dermis of skin tissue at the injection area of rats in blank control group were finely arranged. In simple scar group, a large amount of collagen was deposited in the dermis of skin tissue at the injection area of rats, the fiber bundles were thick and loosely unevenly arranged, and a large number of inflammatory infiltration and scattered muscle fibers were observed. In ADSCs transplantation group, the collagen fibers in the dermis of skin tissue at the injection area of rats were thicker than those of blank control group, with still neat arrangement, and a small amount of scattered muscle fiber and inflammatory infiltration was observed. After 28 days of injection, the expression of α-SMA in ADSCs transplantation group was mainly in microvessels in the dermis of skin tissue at the injected area of rats, and the number of α-SMA and TGF-β(1) positive cells was (49±12) and (63±10) cells per 20-fold field of view, respectively, which was similar to (35±16) and (44±17) cells per 20-fold field of view of blank control group (>0.05), all significantly less than (135±13) and (121±23) cells per 20-fold field of view of simple scar group (<0.05). Compared with those of autologous simple granule fat transplantation, autologous nano-fat mixed granule fat transplantation has better filling fullness in the treatment of patients with scar facial depression and atrophy. The filling effect lasts longer, and the improvement of scar texture is more obvious. As showed in the rat scar model experiment, the mechanism may be that ADSCs inhibit the expressions of α-SMA and TGF-β(1), thus inhibiting the formation of scar.
研究纳米脂肪混合颗粒脂肪移植治疗面部瘢痕凹陷萎缩的临床效果,并探讨其相关实验机制。(1)2012年1月至2018年4月,收治符合纳入标准、需行面部脂肪移植的面部瘢痕凹陷萎缩畸形患者105例,对其病历资料进行回顾性分析。根据患者意愿,将年龄10 - 59岁的54例患者(男12例,女42例)纳入单纯移植组,接受传统的取自腹部/大腿的单纯自体颗粒脂肪移植;将年龄7 - 63岁的51例患者(男14例,女37例)纳入混合移植组,接受取自腹部/大腿的自体纳米脂肪混合颗粒脂肪移植。采用自制量表及手术前后照片资料,从面部饱满度、对称性、瘢痕及并发症等方面评估患者术后3个月和6个月的治疗满意度。术后6个月评估患者是否需二次手术,并计算二次手术率。二次手术时,采集首次手术移植患者的脂肪,在扫描电子显微镜下观察脂肪细胞形态及微血管生成情况。(2)从4周龄雄性Sprague-Dawley(SD)大鼠腹部脂肪中分离培养脂肪干细胞(ADSCs)。选取第5代细胞,培养14天后观察细胞形态,采用免疫荧光法观察波形蛋白和细胞角蛋白-18的表达,鉴定其成骨和成脂分化能力,并用流式细胞仪检测CD29和CD44阳性细胞率(n = 3)。将18只4周龄雄性SD大鼠按随机数字表法分为ADSCs移植组、单纯瘢痕组和空白对照组,每组6只。ADSCs移植组和单纯瘢痕组大鼠于背部皮下注射1 mL质量浓度为1 mg/mL的博来霉素溶解于磷酸盐缓冲液(PBS)中建立瘢痕模型。3小时后,ADSCs移植组大鼠于同一注射部位注射1×10⁶个悬浮于0.1 mL PBS中的ADSCs,单纯瘢痕组大鼠注射0.1 mL PBS。空白对照组大鼠于上述相同两个时间点在相同部位注射相同剂量的PBS。每组连续注射28天后,采集所有大鼠注射部位的全层皮肤组织,采用Masson染色观察胶原纤维,免疫组织化学法观察α-平滑肌肌动蛋白(α-SMA)和转化生长因子β(1)(TGF-β(1))的表达,并计数阳性细胞。数据采用Mann-Whitney检验、χ²检验、单因素方差分析及最小显著差检验。(1)与术前相比,单纯移植组患者术后3个月面部饱满度和对称性较好,瘢痕颜色更接近周围皮肤,该组患者术后6个月的填充量较术后3个月减少。混合移植组患者术后3个月和6个月的面部饱满度和对称性均较术前好,瘢痕颜色和质地更接近周围皮肤,术后6个月的填充量较术后3个月无明显减少。单纯移植组术后3个月内分别有1例患者发生脂肪液化和皮下结节形成。混合移植组患者术后3个月和6个月的治疗满意度显著高于单纯移植组(Z = -2.566,-3.084,P < 0.05或<0.01)。术后6个月,混合移植组患者的二次手术率为7.84%(4/51),显著低于单纯移植组的22.22%(12/54)(χ² = 4.199,P < 0.05)。二次手术时,混合移植组患者首次手术移植脂肪的细胞较单纯移植组更饱满,无塌陷或干瘪,细胞排列紧密,间隙较小;细胞表面的管状和条索状微血管结构更丰富,细胞间隙充满长入脂肪组织的网络状微血管结构。(2)从大鼠脂肪中分离培养的第5代细胞贴壁生长,呈长梭形或纺锤形,呈鱼群样生长。细胞中波形蛋白和细胞角蛋白-18高表达。细胞经诱导显示有成骨和成脂分化能力。CD29和CD44的阳性表达率均高于90.00%。细胞鉴定为ADSCs。注射28天后,空白对照组大鼠注射部位皮肤组织真皮层的胶原纤维排列细密。单纯瘢痕组大鼠注射部位皮肤组织真皮层大量胶原沉积,纤维束粗大且排列疏松不均,可见大量炎性浸润及散在肌纤维。ADSCs移植组大鼠注射部位皮肤组织真皮层的胶原纤维较空白对照组粗,但仍排列整齐,可见少量散在肌纤维及炎性浸润。注射28天后,ADSCs移植组大鼠注射部位皮肤组织真皮层α-SMA的表达主要位于微血管,每20倍视野α-SMA和TGF-β(1)阳性细胞数分别为(49±12)个和(63±10)个,与空白对照组每20倍视野(35±16)个和(44±17)个相似(P > 0.05),均显著少于单纯瘢痕组每20倍视野(135±13)个和(121±23)个(P < 0.05)。与自体单纯颗粒脂肪移植相比,自体纳米脂肪混合颗粒脂肪移植治疗面部瘢痕凹陷萎缩患者具有更好的填充饱满度。填充效果持续时间更长,瘢痕质地改善更明显。大鼠瘢痕模型实验显示,其机制可能是ADSCs抑制α-SMA和TGF-β(1)的表达,从而抑制瘢痕形成。